(Q33943452)

30 July 2017

1 reference

title

T cell design for therapy in autoimmune demyelinating disease (English)

1 reference

30 July 2017

Tuohy VK

1

1 reference

PubMed ID

10854661

30 July 2017

Mathisen PM

series ordinal

2

1 reference

30 July 2017

1 July 2000

1 reference

Journal of Neuroimmunology

30 July 2017

1 reference

30 July 2017

107

1 reference

30 July 2017

2

1 reference

30 July 2017

226-232

1 reference

Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Cell death and control of cell survival in the oligodendrocyte lineage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Adenovirus-mediated regulable target gene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Sustainable cutaneous gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Transcriptional activation by tetracyclines in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

The relationship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Position-effect variegation and the new biology of heterochromatin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Gene therapy in the treatment of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

1 reference

7 January 2021

The basic science of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Regulatory anatomy of the murine interleukin-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cells in the developing rat optic nerve.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

A role for platelet-derived growth factor in normal gliogenesis in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

A humanized system for pharmacologic control of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Cytokines and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

Regression and spreading of self-recognition during the development of autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

1 reference

7 January 2021

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900234-4

7 January 2021

10.1016/S0165-5728(00)00234-4

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10854661